XML 45 R36.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Provided to the CODM | Segment reporting for the three and six months ended June 30, 2025 and 2024 (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Revenue: |  |  |  |  |  |  |  |  |  |  |  |
Product revenue, net |  | $ | 12,800 |  |  | $ | — |  |  | $ | 20,563 |  |  | $ | — |
Revenue under collaboration agreements |  |  | 2,594 |  |  |  | 500 |  |  |  | 2,804 |  |  |  | 500 |
Revenue under supply agreements |  |  | 323 |  |  |  | — |  |  |  | 323 |  |  |  | — |
Total revenue |  |  | 15,717 |  |  |  | 500 |  |  |  | 23,690 |  |  |  | 500 |
Segment operating expenses: |  |  |  |  |  |  |  |  |  |  |  |
Cost of goods sold |  |  | 4,984 |  |  |  | — |  |  |  | 6,078 |  |  |  | — |
Clinical |  |  | 1,250 |  |  |  | 1,226 |  |  |  | 2,454 |  |  |  | 4,042 |
Development |  |  | 2,151 |  |  |  | 2,591 |  |  |  | 3,252 |  |  |  | 4,099 |
Medical affairs |  |  | 1,073 |  |  |  | 421 |  |  |  | 2,018 |  |  |  | 754 |
Sales and marketing |  |  | 40,925 |  |  |  | 2,694 |  |  |  | 67,682 |  |  |  | 4,145 |
General and administrative |  |  | 7,118 |  |  |  | 5,505 |  |  |  | 15,837 |  |  |  | 9,195 |
Stock-based compensation |  |  | 5,371 |  |  |  | 3,365 |  |  |  | 10,669 |  |  |  | 6,680 |
Other |  |  | 459 |  |  |  | 38 |  |  |  | 491 |  |  |  | 117 |
Total segment operating expenses |  |  | 63,331 |  |  |  | 15,840 |  |  |  | 108,481 |  |  |  | 29,032 |
Loss from operations |  |  | (47,614 | ) |  |  | (15,340 | ) |  |  | (84,791 | ) |  |  | (28,532 | )
Other income, net |  |  | 2,731 |  |  |  | 2,824 |  |  |  | 5,968 |  |  |  | 5,724 |
Net loss |  | $ | (44,883 | ) |  | $ | (12,516 | ) |  | $ | (78,823 | ) |  | $ | (22,808 | )

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration